{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:34:26Z","timestamp":1793918066891,"version":"4.8.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jaip.2025.09.040","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:14:39Z","timestamp":1773378879000},"page":"791-801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recommended Vaccines for Immunocompetent Older Adults: A Work Group Report of the AAAAI Asthma, Allergic &amp; Immunologic Diseases in Older Adults Committee"],"prefix":"10.1016","volume":"14","author":[{"given":"Jonathan","family":"Slimovitch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Lockey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7785-4632","authenticated-orcid":false,"given":"Anna Chen","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ballow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan P.","family":"Baptist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotsna","family":"Mullur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoulfia","family":"Allakhverdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmilee M.","family":"Nyenhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Cardet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.09.040_bib1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/ni.2588","article-title":"Understanding immunosenescence to improve responses to vaccines","volume":"14","author":"Goronzy","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2025.09.040_bib2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s11892-013-0425-5","article-title":"Epidemiology of diabetes and diabetes complications in the elderly: an emerging public health burden","volume":"13","author":"Corriere","year":"2013","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jaip.2025.09.040_bib3","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1016\/j.vaccine.2021.04.062","article-title":"Older adults\u2019 vaccine hesitancy: psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake","volume":"39","author":"Nicholls","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2025.09.040_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003826","article-title":"Vaccination uptake amongst older adults from minority ethnic backgrounds: a systematic review","volume":"18","author":"Bhanu","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.jaip.2025.09.040_bib5","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.4049\/jimmunol.174.11.7446","article-title":"The influence of age on T cell generation and TCR diversity1","volume":"174","author":"Naylor","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jaip.2025.09.040_bib6","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.4049\/jimmunol.1302064","article-title":"Age-related decrease in TCR repertoire diversity measured with deep and normalized sequence profiling","volume":"192","author":"Britanova","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jaip.2025.09.040_bib7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.coi.2005.07.020","article-title":"T cell development and receptor diversity during aging","volume":"17","author":"Goronzy","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaip.2025.09.040_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1196\/annals.1354.018","article-title":"Naive T cells in the elderly: are they still there?","volume":"1067","author":"Pfister","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaip.2025.09.040_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.0105-2896.2005.00256.x","article-title":"CD28 extinction in human T cells: altered functions and the program of T-cell senescence","volume":"205","author":"Vallejo","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaip.2025.09.040_bib10","doi-asserted-by":"crossref","first-page":"15053","DOI":"10.1073\/pnas.2433717100","article-title":"CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly","volume":"100","author":"Haynes","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2025.09.040_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.it.2009.03.013","article-title":"CD28(\u2212) T cells: their role in the age-associated decline of immune function","volume":"30","author":"Weng","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaip.2025.09.040_bib12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1023\/A:1006659401385","article-title":"The effect of age on the B-cell repertoire","volume":"20","author":"Weksler","year":"2000","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2025.09.040_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1474-9726.2008.00443.x","article-title":"B-cell diversity decreases in old age and is correlated with poor health status","volume":"8","author":"Gibson","year":"2009","journal-title":"Aging Cell"},{"key":"10.1016\/j.jaip.2025.09.040_bib14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/ar1180","article-title":"Ageing, autoimmunity and arthritis: senescence of the B cell compartment - implications for humoral immunity","volume":"6","author":"Johnson","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaip.2025.09.040_bib15","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.4049\/jimmunol.180.5.2741","article-title":"Mechanisms for decreased function of B cells in aged mice and humans","volume":"180","author":"Frasca","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaip.2025.09.040_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2567.2004.02075.x","article-title":"How do follicular dendritic cells interact intimately with B cells in the germinal centre?","volume":"114","author":"Park","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.jaip.2025.09.040_bib17","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/1521-4141(2002010)32:10<2817::AID-IMMU2817>3.0.CO;2-Z","article-title":"Age-related depression of FDC accessory functions and CD21 ligand-mediated repair of co-stimulation","volume":"32","author":"Aydar","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2025.09.040_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2567.2004.02006.x","article-title":"Age-related loss of na\u00efve T cells and dysregulation of T-cell\/B-cell interactions in human lymph nodes","volume":"114","author":"Lazuardi","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.jaip.2025.09.040_bib19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","article-title":"Immunosenescence: molecular mechanisms and diseases","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaip.2025.09.040_bib20","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jimmun\/vkae036","article-title":"Immunological biomarkers of aging","volume":"214","author":"Wu","year":"2025","journal-title":"J Immunol"},{"key":"10.1016\/j.jaip.2025.09.040_bib22","series-title":"COVID-19 mortality in adults aged 65 and older: United States, 2020","first-page":"1","author":"Tejada-Vera","year":"2022"},{"key":"10.1016\/j.jaip.2025.09.040_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/21501319231170164","article-title":"An analysis of COVID-19 mortality during the dominancy of alpha, delta, and omicron in the USA","volume":"14","author":"Tabatabai","year":"2023","journal-title":"J Prim Care Community Health"},{"key":"10.1016\/j.jaip.2025.09.040_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.29058","article-title":"Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19","volume":"3","author":"Rosenthal","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2025.09.040_bib25","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1093\/geronb\/gbaa114","article-title":"The color of COVID-19: structural racism and the disproportionate impact of the pandemic on older black and Latinx adults","volume":"76","author":"Garcia","year":"2020","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"10.1016\/j.jaip.2025.09.040_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.50145","article-title":"Inpatient costs of treating patients with COVID-19","volume":"7","author":"Kapinos","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2025.09.040_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","article-title":"SARS-CoV-2 pathogenesis","volume":"20","author":"Lamers","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jaip.2025.09.040_bib28","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jaip.2025.09.040_bib29","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.2147\/IDR.S315727","article-title":"Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety","volume":"14","author":"Mascellino","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jaip.2025.09.040_bib30","series-title":"Nuvaxoid [press release]","year":"2025"},{"key":"10.1016\/j.jaip.2025.09.040_bib31","article-title":"The role of B cells in COVID-19 infection and vaccination","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2025.09.040_bib32","series-title":"Fact sheet for healthcare providers administering vaccine: emergency use authorization of Novavax COVID-19 vaccine, adjuvanted (2023-2024 formula), for individuals 12 years of age and Older","year":"2023"},{"key":"10.1016\/j.jaip.2025.09.040_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12941-023-00594-y","article-title":"The efficacy and effectiveness of COVID-19 vaccines around the world: a mini-review and meta-analysis","volume":"22","author":"Soheili","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jaip.2025.09.040_bib34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.20385","article-title":"Estimated number of COVID-19 infections, hospitalizations, and deaths prevented among vaccinated persons in the US, December 2020 to September 2021","volume":"5","author":"Steele","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2025.09.040_bib35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S2213-2600(23)00414-9","article-title":"The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia","volume":"12","author":"Catal\u00e0","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.09.040_bib36","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa2510226","article-title":"Association of 2024\u20132025 Covid-19 vaccine with Covid-19 outcomes in U.S. veterans","volume":"393","author":"Cai","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.09.040_bib37","first-page":"1646","article-title":"Review of adverse events associated with COVID-19 vaccines, highlighting their frequencies and reported cases","volume":"18","author":"Yaamika","year":"2023","journal-title":"J Taibah Univ Med Sci"},{"key":"10.1016\/j.jaip.2025.09.040_bib38","first-page":"839","article-title":"One-year risk of myocarditis after COVID-19 infection: a systematic review and meta-analysis","volume":"39","author":"Zuin","year":"2023","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jaip.2025.09.040_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad192","article-title":"Risk of pneumococcal disease in US adults by age and risk profile","volume":"10","author":"Grant","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jaip.2025.09.040_bib44","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.chest.2020.12.029","article-title":"Geographic variation in racial disparities in mortality from influenza and pneumonia in the United States in the pre-coronavirus disease 2019 era","volume":"159","author":"Donaldson","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.09.040_bib46","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1055\/s-0032-1315634","article-title":"Microbiology and risk factors for community-acquired pneumonia","volume":"33","author":"Sanz Herrero","year":"2012","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2025.09.040_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/1469-0691.12461","article-title":"Pneumococcal infection in adults: burden of disease","volume":"20","author":"Drijkoningen","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jaip.2025.09.040_bib48","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1016\/j.vaccine.2010.05.030","article-title":"Clinical and economic burden of pneumococcal disease in older US adults","volume":"28","author":"Weycker","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2025.09.040_bib49","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10719-023-10100-3","article-title":"Strengths and weaknesses of pneumococcal conjugate vaccines","volume":"40","author":"Micoli","year":"2023","journal-title":"Glycoconj J"},{"key":"10.1016\/j.jaip.2025.09.040_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00937-20","article-title":"A new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral Streptococcus","volume":"11","author":"Ganaie","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.jaip.2025.09.040_bib51","series-title":"PREVNAR 20-pneumococcal 20-valent conjugate vaccine injection, suspension","author":"Label","year":"2023"},{"key":"10.1016\/j.jaip.2025.09.040_bib52","series-title":"About pneumococcal vaccines","year":"2023"},{"key":"10.1016\/j.jaip.2025.09.040_bib53","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3390\/pathogens12050732","article-title":"Systematic review and meta-analysis of the efficacy and effectiveness of pneumococcal vaccines in adults","volume":"12","author":"Farrar","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.jaip.2025.09.040_bib54","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/cid\/ciab990","article-title":"Pivotal phase 3 randomized clinical trial of the safety, tolerability, and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults aged \u226518 years","volume":"75","author":"Essink","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2025.09.040_bib55","series-title":"Merck\u2019s V116, an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults, demonstrated superior immunogenicity for 10 of 11 unique serotypes compared to PCV20 in adults 50 years of age and older","year":"2023"},{"key":"10.1016\/j.jaip.2025.09.040_bib56","article-title":"Serum sickness-like reactions after pneumococcal vaccination","volume":"13","author":"Chung","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jaip.2025.09.040_bib57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.17294\/2330-0698.1214","article-title":"Is 13-valent pneumococcal conjugate vaccine (PCV13) combined with 23-valent pneumococcal polysaccharide vaccine (PPSV23) superior to PPSV23 alone for reducing incidence or severity of pneumonia in older adults? A clin-IQ","volume":"3","author":"Hayward","year":"2016","journal-title":"J Patient Cent Res Rev"},{"key":"10.1016\/j.jaip.2025.09.040_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.mm7401a1","article-title":"Expanded recommendations for use of pneumococcal conjugate vaccines among adults aged \u226550 years: recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2024","volume":"74","author":"Kobayashi","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaip.2025.09.040_bib59","series-title":"Pneumococcal vaccine recommendations","year":"2024"},{"key":"10.1016\/j.jaip.2025.09.040_bib60","doi-asserted-by":"crossref","first-page":"253","DOI":"10.33073\/pjm-2011-035","article-title":"Infections caused by RSV among children and adults during two epidemic seasons","volume":"60","author":"Pancer","year":"2011","journal-title":"Pol J Microbiol"},{"key":"10.1016\/j.jaip.2025.09.040_bib61","article-title":"Rates of medically attended RSV among US adults: a systematic review and meta-analysis","volume":"9","author":"McLaughlin","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jaip.2025.09.040_bib62","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.15585\/mmwr.mm7240a1","article-title":"Characteristics and outcomes among adults aged \u226560 years hospitalized with laboratory-confirmed respiratory syncytial virus \u2014 RSV-NET, 12 states, July 2022\u2013June 2023","volume":"72","author":"Havers","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaip.2025.09.040_bib63","doi-asserted-by":"crossref","first-page":"e1007","DOI":"10.1093\/infdis\/jiae424","article-title":"Residency in long-term care facilities: an important risk factor for respiratory syncytial virus hospitalization","volume":"230","author":"Branche","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaip.2025.09.040_bib64","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1093\/infdis\/jiad559","article-title":"The annual economic burden of respiratory syncytial virus in adults in the United States","volume":"230","author":"Carrico","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaip.2025.09.040_bib65","article-title":"Review of respiratory syncytial virus infection among older adults and transplant recipients","volume":"9","author":"Villanueva","year":"2022","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.jaip.2025.09.040_bib66","first-page":"83","article-title":"Structure and function of respiratory syncytial virus surface glycoproteins","volume":"372","author":"McLellan","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jaip.2025.09.040_bib67","series-title":"Respiratory syncytial virus vaccine, adjuvanted (AREXVY)","year":"2023"},{"key":"10.1016\/j.jaip.2025.09.040_bib69","doi-asserted-by":"crossref","first-page":"166","DOI":"10.58347\/tml.2024.1713d","article-title":"A new RSV vaccine (mResvia) for adults \u226560 years old","volume":"66","year":"2024","journal-title":"Med Lett Drugs Ther"},{"key":"10.1016\/j.jaip.2025.09.040_bib70","doi-asserted-by":"crossref","first-page":"793","DOI":"10.15585\/mmwr.mm7229a4","article-title":"Use of respiratory syncytial virus vaccines in older adults: recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2023","volume":"72","author":"Melgar","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaip.2025.09.040_bib71","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0140-6736(24)01738-0","article-title":"Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis","volume":"404","author":"Payne","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.09.040_bib72","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S2213-2600(25)00048-7","volume":"13","author":"Ison","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.09.040_bib73","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1001\/jama.2025.15405","article-title":"Bivalent RSV prefusion F protein\u2013based vaccine for preventing cardiovascular hospitalizations in older adults: a prespecified analysis of the DAN-RSV trial","volume":"334","author":"Lassen","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2025.09.040_bib74","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa2509810","article-title":"RSV prefusion F vaccine for prevention of hospitalization in older adults","volume":"394","author":"Lassen","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.09.040_bib78","series-title":"US FDA approves expanded age indication for GSK\u2019s Arexvy, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at increased risk","year":"2024"},{"key":"10.1016\/j.jaip.2025.09.040_bib79","series-title":"FDA approves Abrysvo RSV vaccine for adults at increased risk","author":"Steinzor","year":"2024"},{"key":"10.1016\/j.jaip.2025.09.040_bib81","series-title":"Vaccine advisory panel recommends expanded RSV use, and two new vaccines","year":"2025"},{"key":"10.1016\/j.jaip.2025.09.040_bib83","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s12325-023-02432-1","article-title":"High clinical burden of influenza disease in adults aged \u2265 65 years: can we do better? A systematic literature review","volume":"40","author":"Langer","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaip.2025.09.040_bib85","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1016\/j.vaccine.2018.05.057","article-title":"Economic burden of seasonal influenza in the United States","volume":"36","author":"Putri","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2025.09.040_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169344","article-title":"The annual burden of seasonal influenza in the US veterans affairs population","volume":"12","author":"Young-Xu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2025.09.040_bib88","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev.pathmechdis.3.121806.154316","article-title":"The pathology of influenza virus infections","volume":"3","author":"Taubenberger","year":"2008","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jaip.2025.09.040_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2023.100327","article-title":"High-dose influenza vaccine in older adults by age and seasonal characteristics: systematic review and meta-analysis update","volume":"14","author":"Lee","year":"2023","journal-title":"Vaccine X"},{"key":"10.1016\/j.jaip.2025.09.040_bib91","doi-asserted-by":"crossref","first-page":"A24","DOI":"10.1016\/j.vaccine.2020.09.004","article-title":"Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: an updated systematic review and meta-analysis","volume":"39","author":"Lee","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2025.09.040_bib92","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/cid\/ciab1016","article-title":"Interpretation of relative efficacy and effectiveness for influenza vaccines","volume":"75","author":"Lewis","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2025.09.040_bib95","unstructured":"Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention. Summary: prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP- United States, 2023-2024)."},{"key":"10.1016\/j.jaip.2025.09.040_bib96","first-page":"406","article-title":"Shingrix: a new herpes zoster vaccine","volume":"44","author":"Maltz","year":"2019","journal-title":"P T"},{"key":"10.1016\/j.jaip.2025.09.040_bib97","doi-asserted-by":"crossref","first-page":"S429","DOI":"10.1093\/infdis\/jiab387","article-title":"Herpes zoster vaccines","volume":"224","author":"Harbecke","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaip.2025.09.040_bib98","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/j.pain.0000000000001718","article-title":"Aggregate health and economic burden of herpes zoster in the United States: illustrative example of a pain condition","volume":"161","author":"Harvey","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.jaip.2025.09.040_bib99","doi-asserted-by":"crossref","first-page":"11069","DOI":"10.1128\/JVI.00243-07","article-title":"Spontaneous reactivation of herpes simplex virus type 1 in latently infected murine sensory ganglia","volume":"81","author":"Margolis Todd","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jaip.2025.09.040_bib100","series-title":"What everyone should know about the shingles vaccine (Shingrix)","year":"2023"},{"key":"10.1016\/j.jaip.2025.09.040_bib102","author":"Anna Minta"},{"key":"10.1016\/j.jaip.2025.09.040_bib104","author":"Blain"},{"key":"10.1016\/j.jaip.2025.09.040_bib105","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/jnc.15330","article-title":"Tetanus and tetanus neurotoxin: from peripheral uptake to central nervous tissue targets","volume":"158","author":"Megighian","year":"2021","journal-title":"J Neurochem"},{"key":"10.1016\/j.jaip.2025.09.040_bib106","series-title":"Tetanus Vaccines","author":"Edina Avdic","year":"2021"},{"key":"10.1016\/j.jaip.2025.09.040_bib108","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15585\/mmwr.mm6903a5","article-title":"Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2019","volume":"69","author":"Havers","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826001236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826001236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:37:22Z","timestamp":1775554642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219826001236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2213219826001236"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.09.040","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommended Vaccines for Immunocompetent Older Adults: A Work Group Report of the AAAAI Asthma, Allergic & Immunologic Diseases in Older Adults Committee","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.09.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2026.01.039","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}